Unresectable Solid Tumor
17 clinical trials · Condition
◉ Watch Unresectable Solid Tumor
| Record | Firm | Date |
|---|---|---|
| Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA (NCT05461664) | Xinhua Zhang, MD | 2022-07-10 |
| A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors (NCT05464875) | Xinhua Zhang, MD | 2022-07-09 |
| First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer (NCT05216432) | Relay Therapeutics, Inc. | 2021-12-08 |
| A Study of RC118 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours (NCT04914117) | RemeGen Co., Ltd. | 2021-11-29 |
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
Track Unresectable Solid Tumor automatically
Every clearance here is in the API, with alerts when new ones post.